Human chorionic gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone > 300 ng/dL

Madhusoodanan, Vinayak; Patel, Premal; Lima, Thiago Fernandes Negris; Gondokusumo, Jabez; Lo, Eric; Thirumavalavan, Nannan; Lipshultz, Larry I; Ramasamy, Ranjith.
Int. braz. j. urol ; 45(5): 1008-1012, Sept.-Dec. 2019. tab
Artigo em Inglês | LILACS | ID: biblio-1040079

Documentos relacionados

  1. Human Chorionic Gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone > 300 ng/dL.
  2. Optimal treatment for spermatogenesis in male patients with hypogonadotropic hypogonadism.
  3. [Hypogonadism due to LH deficiency].
  4. Testosterone therapy over 60 months improves aging male symptoms scores in all men with adult-onset testosterone deficiency.
  5. Cardiovascular Safety of Testosterone-Replacement Therapy.
  6. Prediction of testosterone response to human chorionic gonadotrophin in idiopathic hypogonadotropic hypogonadism patients.
  7. Clomiphene citrate and human chorionic gonadotropin are both effective in restoring testosterone in hypogonadism: a short-course randomized study.
  8. Luteal phase HCG support for unexplained recurrent pregnancy loss - a low hanging fruit?
  9. Prognostic value of total testosterone for pregnancy during treatment in patients with clomiphene-citrate-resistant polycystic ovary syndrome: a pilot study.
  10. Advances in stem cell research for the treatment of primary hypogonadism.